Life-Threatening SARS-CoV-2–Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022–2024

Read full text
Authors: Mariko Kasai, Hiroshi Sakuma, Motomasa Suzuki, Masahiro Nishiyama, Nanako Kawata, Jainn-Jim Lin, Kuang-Lin Lin, Velda Xinying Han, Shekeeb S. Mohammad, Russell C. Dale, Terrence Gerard Sundram Thomas, Kazuhiro Muramatsu
+6 more Osamu Mitani, Yoshiyuki Kobayashi, Kouhei Ishida, Yuichi Abe, Ichiro Kuki, Jun-ichi Takanashi
Cited by: 1
References: 30

Abstract

SARS-CoV-2 infections in children occasionally manifest with severe neurologic signs. We report a case series of life-threatening encephalopathy associated with SARS-CoV-2 in 25 children in Australia, Japan, Singapore, and Taiwan during February 2022-January 2024. All children had severe encephalopathy develop, characterized by rapidly progressive cerebral edema, conditions known as acute shock with encephalopathy and multiorgan failure or acute fulminant cerebral edema. Among the 25 patients, 22 (88%) eventually died; 11 (44%) children died within 24 hours of hospitalization. In addition, 18 (72%) had illness manifest with shock, and 14 (56%) had multiorgan failure develop within 6 hours of neurologic onset. Serum concentrations of cytokines/chemokines including interleukin 6 and tumor necrosis factor-α were significantly higher within 24 hours of onset than for controls. SARS-CoV-2-associated encephalopathy cases such as those described here represent an emerging neurologic crisis with high mortality rate resulting from rapidly progressive brain edema and multiorgan failure.

Fields of Study & Subjects

Long-Term Effects of COVID-19 Infectious Encephalopathies and Encephalitis COVID-19 Clinical Research Studies

Publication details

Journal / source
Emerging infectious diseases
Publisher
Centers for Disease Control and Prevention (CDC)
Volume
32
Issue
2
Pages
169–179
Publication date
1 February 2026
Language
EN